Parallel, fast, sensitive miniaturized immunoassays for point-of-care testing based on autonomous microfluidic chips

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

7936.2;4 NMPP-NM

Projekttitel

Parallel, fast, sensitive miniaturized immunoassays for point-of-care testing based on autonomous microfluidic chips

Projekttitel Englisch

Parallel, fast, sensitive miniaturized immunoassays for point-of-care testing based on autonomous microfluidic chips

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung	-	-	-
Abstract	-	-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Englisch)	Parallel, fast, sensitive miniaturized immunoassays for point-of-care testing based on autonomous microfluidic chips
Abstract (Englisch)	The goal of the project is to enable parallel, quantitative immunoassays using ultra small volumes of sample to detect multiple analytes in a minimum of time and with high sensitivity. Such assays are not available with current technology. Key for success will be to build on our established proof of concept to combine the small form factor of chip technology and the small sample volumes of microfluidics with innovative fluid handling, surface functionalization and efficient signal detection/analysis principles. Chip design, immunoassay development and clinical validation needed for commercialization are part of the research plan.

Kategorie

Text

Kurzbeschreibung
(Englisch)

Parallel, fast, sensitive miniaturized immunoassays for point-of-care testing based on autonomous microfluidic chips

Abstract
(Englisch)

The goal of the project is to enable parallel, quantitative immunoassays using ultra small volumes of sample to detect multiple analytes in a minimum of time and with high sensitivity. Such assays are not available with current technology. Key for success will be to build on our established proof of concept to combine the small form factor of chip technology and the small sample volumes of microfluidics with innovative fluid handling, surface functionalization and efficient signal detection/analysis principles. Chip design, immunoassay development and clinical validation needed for commercialization are part of the research plan.